Evidence map›Paper›PMID 25664854›Full record

ArticleThe Journal of clinical investigation2015

Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.

Giovanna Leoni, Philipp-Alexander Neumann, Nazila Kamaly, Miguel Quiros, Hikaru Nishio, Hefin R Jones, Ronen Sumagin, Roland S Hilgarth, Ashfaqul Alam, Gabrielle Fredman and 9 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 2 syntheses or guidelines pooled it, 364 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Pro-resolving Annexin A1-derived peptide Ac2-26 reduces nociception and mitigates joint damage in experimental osteoarthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 4 countries.

Giovanna Leoni
Philipp-Alexander Neumann
Nazila Kamaly
Miguel Quiros
Hikaru Nishio
Hefin R Jones
Ronen Sumagin
Roland S Hilgarth
Ashfaqul Alam
Gabrielle Fredman
Ioannis Argyris
Emile Rijcken
Dennis Kusters
Chris Reutelingsperger
Mauro Perretti
Charles A Parkos
Omid C Farokhzad
Andrew S Neish
Asma Nusrat
Emory University · USBrigham and Women's Hospital · USMaastricht University · NLUniversity of Münster · DEWilliam Harvey Research Institute · GBColumbia University · USUniversity of Michigan–Ann Arbor · US

Funding

University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Intestinal Mucosal Wound Resealing in IBDR01DK055679 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ASMA NUSRAT · 2004 to 2026
$8.1M
Intestinal Inflammation: Signaling proteins and the rate of PMN transmigrationR01DK079392 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PARKOS, CHARLES A · 2007 to 2025
$7.2M
Neutrophil Interactions with Intestinal Epithelial CellsR01DK072564 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PARKOS, CHARLES A · 2005 to 2020
$6.5M
Structure-Function Studies on Intestinal Epithelial JAMR01DK061379 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PARKOS, CHARLES A · 2002 to 2021
$6.3M
Microbial Influence on Mucosal HomeostasisR01AI064462 · NIAID · EMORY UNIVERSITY · PI NEISH, ANDREW S · 2006 to 2022
$5.5M
Emory Epithelial Pathobiology Research Development CenterR24DK064399 · NIDDK · EMORY UNIVERSITY · PI PARKOS, CHARLES A · 2003 to 2012
$5.3M
Formyl peptide receptors as mediators of intestinal mucosal homeostasisR01DK089763 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NEISH, ANDREW S, NUSRAT, ASMA · 2011 to 2020
$4.7M
Neutrophil interactions with apical ICAM-1 regulate intestinal epithelial homeostK01DK101675 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SUMAGIN, RONEN · 2014 to 2018
$710k
NHLBI NIH HHS HHSN268201000045CNIAID NIH HHS R01 AI064462NIAID NIH HHS R01AI64462NIDDK NIH HHS DK061379NIDDK NIH HHS DK 064399NIDDK NIH HHS DK072564NIDDK NIH HHS DK079392NIDDK NIH HHS K01 DK101675NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R01 DK055679NIDDK NIH HHS R01DK055679NIDDK NIH HHS R01 DK061379NIDDK NIH HHS R01 DK072564NIDDK NIH HHS R01 DK079392NIDDK NIH HHS R01 DK089763NIDDK NIH HHS R01DK089763NIDDK NIH HHS R24 DK064399Wellcome TrustWellcome Trust 10160Z13Z
6 · The paper itself

Abstract

Epithelial restitution is an essential process that is required to repair barrier function at mucosal surfaces following injury. Prolonged breaches in epithelial barrier function result in inflammation and further damage; therefore, a better understanding of the epithelial restitution process has potential for improving the development of therapeutics. In this work, we demonstrate that endogenous annexin A1 (ANXA1) is released as a component of extracellular vesicles (EVs) derived from intestinal epithelial cells, and these ANXA1-containing EVs activate wound repair circuits. Compared with healthy controls, patients with active inflammatory bowel disease had elevated levels of secreted ANXA1-containing EVs in sera, indicating that ANXA1-containing EVs are systemically distributed in response to the inflammatory process and could potentially serve as a biomarker of intestinal mucosal inflammation. Local intestinal delivery of an exogenous ANXA1 mimetic peptide (Ac2-26) encapsulated within targeted polymeric nanoparticles (Ac2-26 Col IV NPs) accelerated healing of murine colonic wounds after biopsy-induced injury. Moreover, one-time systemic administration of Ac2-26 Col IV NPs accelerated recovery following experimentally induced colitis. Together, our results suggest that local delivery of proresolving peptides encapsulated within nanoparticles may represent a potential therapeutic strategy for clinical situations characterized by chronic mucosal injury, such as is seen in patients with IBD.

Indexed as

AnimalsAnnexin A1Anti-Inflammatory AgentsCell LineColitisExosomesHumansIntestinal MucosaMice, KnockoutNanoparticlesPeptidesWound HealingAnnexin A1annexin A1 peptide (2-26)Anti-Inflammatory AgentsPeptides

Identifiers

PMID25664854
PMCPMC4362251
OpenAlexW1982159359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.